- Report
- August 2022
- 244 Pages
Global
From €3420EUR$3,600USD£2,933GBP
- Report
- November 2023
- 92 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£774GBP
- Report
- November 2023
- 140 Pages
Global
From €2849EUR$2,999USD£2,443GBP
- Report
- June 2022
- 150 Pages
Global
From €3283EUR$3,456USD£2,815GBP
- Book
- June 2022
- 560 Pages
- Book
- March 2020
United States
Particle therapy is a type of radiation therapy used to treat cancer. It uses beams of protons or other particles to deliver a precise dose of radiation to the tumor, minimizing damage to surrounding healthy tissue. This type of therapy is particularly useful for treating tumors located near sensitive organs, such as the brain, spinal cord, and eyes. It is also used to treat tumors that are difficult to reach with traditional radiation therapy.
Particle therapy is becoming increasingly popular in the oncology drugs market, as it offers a more targeted approach to treating cancer. It is also associated with fewer side effects than traditional radiation therapy, making it a more attractive option for patients.
Some of the companies in the particle therapy market include Varian Medical Systems, Elekta, IBA, Hitachi, and ProTom International. Show Less Read more